The Impact of Programmed Death-Ligand 1 Expression on the Prognosis of Early Stage Resected Non-Small Cell Lung Cancer: A Meta-Analysis of Literatures

INTRODUCTION: Previous studies have demonstrated that programmed cell death-ligand 1 (PD-L1) serves as biomarker for poor prognosis and survival in advanced-stage non-small cell lung cancer (NSCLC) patients. However, the merit of PD-L1 expression to predict the prognosis of early stage NSCLC patient...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Front Oncol
Autors principals: Shi, Tao, Zhu, Shuai, Guo, Hengjuan, Li, Xiongfei, Zhao, Shikang, Wang, Yanye, Lei, Xi, Huang, Dingzhi, Peng, Ling, Li, Ziming, Xu, Song
Format: Artigo
Idioma:Inglês
Publicat: Frontiers Media S.A. 2021
Matèries:
Oncology
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7940546/
https://ncbi.nlm.nih.gov/pubmed/33708622
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fonc.2021.567978
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars